|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contributor Cindy H. Dubin interviews several leading companies on how they are using innovative technologies, such as lipid nanoparticles to achieve a high drug loading, combining anti-solvent continuous crystallization with micro-mixing technology to control crystallization and reduce crystal size, and how a robotic capsule can improve bioavailability in the range of 47% to 78%.
|
|
|
Andrew Thomson, Brian Carpenter, and Robert Broadnax focus on how developers must strategically address and overcome specific challenges to successfully drive development and eventual adoption of microbiome-based therapies.
|
|
|
Christian Marcazzo explains how adopting a new kind of data strategy might be disruptive to the expectation of how biologics development is carried out — but it may also be transformational.
|
|
|
Dr. Joseph F. Bristow, Chief Technology Officer for Kytosan USA, discusses chitosan and its impact on the pharmaceutical industry, as well as Kytosan USA’s production plans.
|
|
|
|
|
|
|
|
|

Eurofins BioPharma Product Testing offers complete CMC Testing Services for the Bio/Pharmaceutical industry, including all starting materials, process intermediates, drug substances, drug product, packaging, and manufacturing support through our broad technical expertise in Biochemistry, Molecular & Cell Biology, Virology, Chemistry, and Microbiology. With a global capacity of more than 2,000,000 square feet of facilities and 37 locations worldwide, our network of GMP laboratories and vast experience allow us to support projects of any size from conception to market. Click here for more.

Video Spotlight: MilliporeSigma (Ready-to-Use Buffers)

|
|
|
|
|
|
 |
|
Three leading companies in their respective fields – DFE Pharma (excipients solution provider), Harro Höfliger (equipment supplier), and Sterling (API manufacturer) recently announced a unique partnership….
|
|
 |
|
Gerresheimer ceremoniously took over a new building in Berlin, Ohio. In the future, the square plastic containers of the Duma Twist-Off Q brand with a 40-ml filling volume….
|
|
 |
|
GeoVax Labs, Inc. recently announced the U.S. Patent and Trademark Office has issued Patent No. 11278607 to GeoVax, pursuant to the company’s patent application No. 16/068,527 titled….
|
|
 |
|
Jeune Aesthetics, Inc., a wholly owned subsidiary of Krystal Biotech, Inc., recently announced positive proof-of-concept efficacy data from Cohort 2 of the PEARL-1 study of KB301….
|
|
 |
|
Oasmia Pharmaceutical AB and Lonza recently announced the companies have signed a large-scale manufacturing agreement for the main drug intermediate in the supply of….
|
|
|
|
|
|
|
|
 |
|
The Rule of 5 suggests that, for oral bioavailability, a better chance for oral absorption is obtained when the molecules are within the parameters of the Rule of 5’. However, the pharmaceutical industry is achieving oral efficacy with drugs that exceed….
|
|
 |
|
There have been many challenges holding back widespread adoption of self-administered injectable formulations. One of the most pressing is the need to develop an auto-injector with a fine enough needle for….
|
|
|
|
|
|
|
|
 |
|
Are you prepared for the HFA phasedown? With many industries switching to more environmentally friendly propellants, pMDI developers need to be ready. Recipharm explore alternative technologies to HFA propellants, and how the devices and formulations can be optimized to ensure …
|
|
 |
|
By: Alexandra H. Heussner, PhD, Laboratory Manager ASL, and Melanie Zerulla-Wernitz, PhD, Head of ASL, Development Service, Vetter Pharma-Fertigung GmbH & Co. KG
In the pharmaceutical manufacturing process, a relatively new class of parenteral drug products on the market – …
|
|
|
|
|
Upcoming eNewsletter Features:
April 6 – Excipients
April 13 – Prefilled Syringes
|
|
|
|
|
|
|
|